Myrcludex B

Need Assistance?

  • US & Canada:
    +
  • UK: +
Myrcludex B
* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Myrcludex B is a drug candidate for the treatment of hepatitis B and D. It is under a phase II clinical trial. Myrcludex B acts by inhibiting the sodium taurocholate cotransporting polypeptide.

Category
Peptide Inhibitors
Catalog number
BAT-010104
CAS number
2012558-47-1
Molecular Formula
C248H355N65O72
Molecular Weight
5398.95
Myrcludex B
Size Price Stock Quantity
5 mg $1099 In stock
Bulk Inquiry
Synonyms
MyrB; Myrcludex-B; Hepatera; MYR Pharma; Vision7; Bulevirtide
Purity
≥98%
Sequence
Myristoyl-GTNLSVPNPLGFFPDHQLDPAFGANSNNPDWDFNPNKDHWPEANKVG
Storage
Store at -20°C

Online Inquiry

Verification code
Inquiry Basket